Grifois, S.A. (GRFS)
NASDAQ
$7.35+$0.1500 (+2.08%) on the dayAs of the close; data may be delayed.
GRFS price, last 12 months
Key stats
- Previous close
- $7.20
- Open
- $7.36
- Day range
- $7.29 – $7.39
- 52-week range
- $6.96 – $10.23
- Volume
- 507.2K
- Avg volume (20 days)
- 600.8K
- Market cap
- $5.0B
Performance
1W+0.6%
1M−7.0%
3M−0.5%
6M−3.5%
YTD−21.4%
1Y−25.5%
vs S&P 500, 1Y−42.2 pts
Technicals and fundamentals
About Grifois, S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
- Listed on
- NASDAQ
- Market cap
- $5.0B